IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

NCT06139328 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

160

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Myocardial Infarction

Interventions

DRUG: BI 765845
DRUG: Placebo matching BI 765845

Sponsor

Boehringer Ingelheim